John P Richard Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John P Richard.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John P Richard. John P Richard is Director in Aviragen Therapeutics, Inc. ($NABI) and Director in CATALYST BIOSCIENCES, INC. ($CBIO) and Director in Altus Pharmaceuticals Inc. ($ALTU).
Latest Insider Trading Transactions of John P Richard
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALTU, CBIO, VXRT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 13 2020 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Buy | P | 3.98 | 2,500 | 9,950 | 3,716 | 1.2 K to 3.7 K (+205.59 %) |
Oct 15 2019 | AVIR | Vaxart, Inc. | Richard John P | Director | Buy | P | 0.38 | 20,000 | 7,680 | 20,000 | 0 to 20 K |
Jun 17 2019 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | A | 7.46 | 5,000 | 37,300 | 5,000 | |
Jun 14 2019 | AVIR | Vaxart, Inc. | Richard John P | Director | Option Exercise | A | 0.68 | 12,700 | 8,636 | 12,700 | |
Jun 14 2019 | AVIR | Vaxart, Inc. | Richard John P | Director | Option Exercise | A | 0.68 | 9,000 | 6,120 | 9,000 | |
May 28 2019 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Buy | P | 8.03 | 1,000 | 8,030 | 1,216 | 216 to 1.2 K (+462.96 %) |
Jun 15 2018 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | A | 24.94 | 5,000 | 124,700 | 5,000 | |
Jul 17 2017 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | A | 4.40 | 10,000 | 44,000 | 10,000 | |
May 22 2017 | AVIR | Aviragen Therapeut ... | Richard John P | Director | Option Exercise | A | 0.49 | 20,000 | 9,800 | 105,000 | |
Jun 13 2016 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | A | 1.88 | 7,500 | 14,100 | 7,500 | |
May 13 2016 | NABI | Aviragen Therapeut ... | Richard John P | Director | Option Exercise | A | 1.50 | 20,000 | 30,000 | 20,000 | |
Oct 26 2015 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | A | 4.40 | 6,750 | 29,700 | 6,750 | |
Oct 26 2015 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | A | 4.40 | 8,250 | 36,300 | 8,250 | |
Aug 13 2015 | NABI | Aviragen Therapeut ... | Richard John P | Director | Option Exercise | A | 2.49 | 5,000 | 12,450 | 5,000 | |
May 14 2015 | NABI | Aviragen Therapeut ... | Richard John P | Director | Option Exercise | A | 2.20 | 15,000 | 33,000 | 15,000 | |
Jun 28 2007 | ALTU | Altus Pharmaceutic ... | Richard John P | Director | Option Exercise | A | 11.85 | 13,083 | 155,034 | 13,083 | |
Mar 30 2007 | ALTU | Altus Pharmaceutic ... | Richard John P | Director | Option Exercise | A | 15.11 | 4,361 | 65,895 | 4,361 | |
Feb 05 2007 | ALTU | Altus Pharmaceutic ... | Richard John P | Director | Option Exercise | A | 18.45 | 1,090 | 20,111 | 1,090 | |
Nov 17 2006 | ALTU | Altus Pharmaceutic ... | Richard John P | Director | Option Exercise | A | 18.98 | 8,722 | 165,544 | 8,722 |
Page: 1